Aevi Genomic down 6% on Q1 result [Seeking Alpha]
Diebold Nixdorf Incorporated Common stock (DBD)
Last diebold nixdorf incorporated common stock earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.dieboldnixdorf.com
Company Research
Source: Seeking Alpha
Aevi Genomic down 6% on Q1 resultAevi Genomic (GNMX)Q1 results: Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%).Q1 Highlights: AEVI-001: The Company continues screening and recruitment efforts for its Phase 2 (ASCEND) clinical trial.Data from the study are expected by mid-2018.AEVI-002: The Company has completed the addition of three new clinical sites and patient screening is underway for its Phase 1b open-label study which will evaluate the safety, tolerability and short-term efficacy in diseased patients that have previously failed anti-TNFa treatment. Data from the study are expected by the end of 2018.AEVI-005: The Company intends to initiate a preclinical research program in collaboration with Kyowa Hakko Kirin during Q2 2018.Shares are down6% premarket.See all stocks on the move »Now read:Concordia International down 7% on Q1 result »
Show less
Read more
Impact Snapshot
Event Time:
DBD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DBD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DBD alerts
High impacting Diebold Nixdorf Incorporated Common stock news events
Weekly update
A roundup of the hottest topics
DBD
News
- Turkey Point Of Sale Terminals Market Analysis Report 2024-2030 Featuring Verifone Systems, PAX Technology, Diebold Nixdorf, Toshiba, Ingenico, and Square [Yahoo! Finance]Yahoo! Finance
- What Makes Diebold Nixdorf, Incorporated (DBD) a Good Fit for 'Trend Investing' [Yahoo! Finance]Yahoo! Finance
- Diebold Nixdorf, Incorporated (NYSE:DBD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Diebold Nixdorf, Incorporated (NYSE: DBD) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $50.00 price target on the stock, up previously from $40.00.MarketBeat
- Diebold Nixdorf Reports 2024 First Quarter Financial ResultsPR Newswire
DBD
Earnings
- 5/3/24 - Beat
DBD
Sec Filings
- 5/10/24 - Form SC
- 5/7/24 - Form 4
- 5/6/24 - Form 4
- DBD's page on the SEC website